Evidence map›Paper›PMID 39467037›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2025

Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project.

Sara Faghihi-Kashani, Akira Yoshida, Francisca Bozan, Giovanni Zanframundo, Davide Rozza, Aravinthan Loganathan, Eduardo Dourado, Gianluca Sambataro, Iazsmin Bauer-Ventura, Sangmee Sharon Bae and 46 more

Abstract readMulticenter Study
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

56 authors.

Sara Faghihi-KashaniUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.ORCID 0000-0001-5948-0297
Akira YoshidaNippon Medical School Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0003-3590-1637
Francisca BozanHospital Clínico Universidad de Chile, Santiago, Chile.ORCID 0009-0004-2711-0434
Giovanni ZanframundoUniversità di Pavia and Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.ORCID 0000-0001-5042-1282
Davide RozzaItalian Society of Rheumatology, Milan, Italy.ORCID 0000-0003-2648-742X
Aravinthan LoganathanRoyal National Hospital for Rheumatic Diseases and University of Bath, Bath, UK, and Arthritis Australia, Broadway, Glebe, New South Wales, Australia.ORCID 0000-0003-3576-7204
Eduardo DouradoCentro Hospitalar do Baixo Vouga and Egas Moniz Health Alliance, Aveiro, and Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.ORCID 0000-0003-2186-2833
Gianluca SambataroPoliclinico G. Rodolico-San Marco, University of Catania, Catania, Italy.ORCID 0000-0001-9933-1202
Iazsmin Bauer-VenturaUniversity of Chicago, Chicago, Illinois.ORCID 0000-0003-1306-4241
Sangmee Sharon BaeDavid Geffen School of Medicine, University of California, Los Angeles, California.ORCID 0000-0002-7216-7219
Darosa LimPerelman School of Medicine & Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, Pennsylvania.ORCID 0000-0003-2707-8134
Daphne Rivero-GallegosInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.ORCID 0009-0003-9918-3459
Yasuhiko YamanoTosei General Hospital, Seto, Japan.ORCID 0000-0002-7779-9215
Albert Selva-O'CallaghanVall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0003-2823-9761
Andrew L MammenNational Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, and Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0003-3732-3252
Carlo A ScirèUniversity of Milano Bicocca, Milan, and Istituto di Ricovero e Cura a Carattere Scientifico San Gerardo dei Tintori Foundation, Monza, Italy.ORCID 0000-0001-7451-0271
Carlomaurizio MontecuccoUniversità di Pavia and Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.ORCID 0000-0001-8263-3925
Chester V OddisUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.ORCID 0000-0002-9529-3111
David FiorentinoStanford University School of Medicine, Redwood City, California.ORCID 0000-0001-7951-3674
Francesco BonellaRuhrlandklinik University Hospital, University of Duisburg-Essen, Essen, Germany.ORCID 0000-0001-7579-9767
Frederick W MillerNational Institute of Environmental Health Sciences, NIH, Durham, North Carolina.ORCID 0000-0003-2831-9593
Ingrid E LundbergKarolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-6068-9212
Jens SchmidtUniversity Medical Center Göttingen, Göttingen, Germany, and Immanuel Klinik Rüdersdorf, University Hospital of the Brandenburg Medical School and Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany.ORCID 0000-0002-5589-2371
Jorge Rojas-SerranoInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.ORCID 0000-0001-6980-7898
Marie HudsonMcGill University, Montreal, Quebec, Canada.ORCID 0000-0001-6718-2468
Masataka KuwanaNippon Medical School Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0001-8352-6136
Miguel Angel González-GayInstituto de Investigación Sanitaria-Fundación Jiménez Díaz, Madrid, and University of Cantabria, Santander, Spain.ORCID 0000-0002-7924-7406
Neil McHughUniversity of Bath, Bath, UK.ORCID 0000-0003-2765-658X
Tamera J CorteRoyal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-5076-8929
Tracy Jennifer DoyleBrigham and Women's Hospital, Boston, Massachusetts.ORCID 0000-0002-0770-1059
Victoria P WerthPerelman School of Medicine & Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, Pennsylvania.ORCID 0000-0003-3030-5369
Latika GuptaRoyal Wolverhampton Hospitals NHS Trust, Wolverhampton, and The University of Manchester, Manchester, UK.ORCID 0000-0003-2753-2990
Diana Isabel Perez RomanInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.ORCID 0000-0003-3325-9214
Lorenzo M BianchessiUniversità di Pavia, Pavia, Italy.
Phani Kumar DevarasettiThe University of Manchester, Manchester, UK.ORCID 0000-0002-6251-7828
Samuel Katsuyuki ShinjoFaculdade de Medicina Faculdade de Medicina, Universidade de São Paulo, Universidade de Sao Paulo, Sao Paulo, Brazil.ORCID 0000-0002-3682-4517
Fabrizio LuppiUniversity of Milano Bicocca, Monza, Italy.ORCID 0000-0001-5775-5947
Ilaria CavazzanaUniversity and Azienda Ospedaliera Spedali Civili, Brescia, Italy.ORCID 0000-0002-2757-7120
Siamak Moghadam-KiaUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.ORCID 0000-0002-0994-1590
Marco FornaroUniversity of Bari, Bari, Italy.ORCID 0000-0003-1716-7432
Elizabeth R VolkmannDavid Geffen School of Medicine, University of California, Los Angeles, California.ORCID 0000-0003-3750-6569
Matteo PigaUniversity of Cagliari and Azienda Ospedaliera Universitaria Cagliari, Cagliari, Italy.ORCID 0000-0002-1126-8315
Jesus Loarce-MartosHospital Universitario Ramón y Cajal, Madrid, Spain.ORCID 0000-0003-1352-9539
Giacomo De LucaVita-Salute San Raffaele University & Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Hospital, Milan, Italy.ORCID 0000-0002-5306-7714
Johannes KnitzaUniversity Hospital of Giessen and Marburg, Philipps-University Marburg, Marburg, and Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.ORCID 0000-0001-9695-0657
Veronica Wolff-CecchiInstituto Nacional del Torax and Universidad de Chile, Santiago, Chile.ORCID 0000-0001-9924-4950
Marco SebastianiGuglielmo da Saliceto Hospital of Piacenza, University of Parma, Parma, Italy.ORCID 0000-0002-1294-6421
Adam SchiffenbauerNational Institute of Environmental Health Sciences, NIH, Bethesda, Maryland.ORCID 0000-0001-9964-9966
Lisa G RiderNational Institute of Environmental Health Sciences, NIH, Bethesda, Maryland.ORCID 0000-0002-6912-2458
Raquel Campanilho-MarquesFaculdade de Medicina, Universidade de Lisboa and Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.ORCID 0000-0002-1894-8516
Lucian MartsEmory University School of Medicine, Atlanta, Georgia.ORCID 0000-0003-3210-8051
Elena BraviOspedale Guglielmo da Saliceto, Piacenza, Italy.ORCID 0000-0002-4416-2568
Harsha GunawardenaNorth Bristol NHS Trust, Bristol, UK.ORCID 0009-0001-2197-5582
Rohit AggarwalUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.ORCID 0000-0001-7531-8038
Lorenzo CavagnaUniversità di Pavia and Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.ORCID 0000-0003-3292-1528
Classification Criteria for Anti‐Synthetase Syndrome Project participating investigators

Funding

Assessment, Therapy and Prevention Of Autoimmune DiseaseZIAES101081 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI RIDER, LISA · 2009 to 2025
$17.6M
A nonpsychoactive cannabinoid receptor-2 agonist to treat itch and inflammation in dermatomyositisR01AR076766 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI WERTH, VICTORIA P · 2020 to 2023
$1.7M
American College of Rheumatology Research and Education FoundationEuropean League Against RheumatismIntramural NIH HHS ZIA ES101081NIAMS NIH HHS R01 AR076766NIEHS NIH HHS ZIA ES101081
6 · The paper itself

Abstract

objectiveAnti-synthetase syndrome (ASSD) is a rare systemic autoimmune rheumatic disease (SARD) with significant heterogeneity and no shared classification criteria. We aimed to identify clinical and serological features associated with ASSD that may be suitable for inclusion in the data-driven classification criteria for ASSD.

methodsWe used a large, international, multicenter "Classification Criteria for Anti-synthetase Syndrome" (CLASS) project database, which includes both patients with ASSD and controls with mimicking conditions, namely, SARDs and/or interstitial lung disease (ILD). The local diagnoses of ASSD and controls were confirmed by project team members. We employed univariable logistic regression and multivariable Ridge regression to evaluate clinical and serological features associated with an ASSD diagnosis in a randomly selected subset of the cohort.

resultsOur analysis included 948 patients with ASSD and 1,077 controls. Joint, muscle, lung, skin, and cardiac involvement were more prevalent in patients with ASSD than in controls. Specific variables associated with ASSD included arthritis, diffuse myalgia, muscle weakness, muscle enzyme elevation, ILD, mechanic's hands, secondary pulmonary hypertension due to ILD, Raynaud phenomenon, and unexplained fever. In terms of serological variables, Jo-1 and non-Jo-1 anti-synthetase autoantibodies, antinuclear antibodies with cytoplasmic pattern, and anti-Ro52 autoantibodies were associated with ASSD. In contrast, isolated arthralgia, dysphagia, electromyography/magnetic resonance imaging/muscle biopsy findings suggestive of myopathy, inflammatory rashes, myocarditis, and pulmonary arterial hypertension did not differentiate between patients with ASSD and controls or were inversely associated with ASSD.

conclusionWe identified key clinical and serological variables associated with ASSD, which will help clinicians and offer insights into the development of data-driven classification criteria for ASSD.

Indexed as

Autoimmune DiseasesMyositisAdultAgedAntibodies, AntinuclearArthritisAutoantibodiesCase-Control StudiesFemaleHumansHypertension, PulmonaryLung Diseases, InterstitialMaleMiddle AgedMuscle WeaknessAntibodies, AntinuclearAutoantibodies

Identifiers

PMID39467037
PMCPMC11936500

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.